Sufentanil

Generic Name: Sufentanil

Brand Names: Dsuvia, Sufenta, Dzuveo

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₃₀N_₂O_₂S

CAS Number: 56030-54-7

Unique Ingredient Identifier: AFE2YW0IIZ

Background: Sufentanil is an opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent. It is administered by the intravenous, epidural and sublingual routes.
...

Indication: The indications for this drug are as follows:

Associated Conditions: Acute Pain, Severe Acute Pain

Associated Therapies: General Anesthesia, Induction and Maintenance of General Anesthesia, Lumbar epidural anesthesia therapy, Short opioid analgesia requirement

Clinical Trials

Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001

Phase 2

Completed

Conditions: Pain

Interventions: Drug: CT001
Drug: Placebo
Drug: Sufentanil
Drug: Ketamine

First Posted Date: 2022-08-19

Last Posted Date: 2023-10-18

Lead Sponsor: Cessatech A/S

Target Recruit Count: 220

Registration Number: NCT05508594

Locations: 🇩🇰
DanTrials, Copenhagen, NV, Denmark

Cardiac Index and General Anesthesia Without Opioid.

Phase 2

Recruiting

Conditions: Hip Arthropathy
Hip Disease

Interventions: Drug: Dexmedetomidine
Drug: Sufentanil

First Posted Date: 2022-07-06

Last Posted Date: 2023-02-08

Lead Sponsor: Centre Hospitalier de Montauban

Target Recruit Count: 120

Registration Number: NCT05446623

Locations: 🇫🇷
Edmundo Pereira de Souza Neto, Montauban, Tarn Et Garonne, France

Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients

Not Applicable

Completed

Conditions: Hemodynamic Instability

Interventions: Drug: REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]
Drug: Propofol
Drug: Rocuronium
Drug: Sufentanil

First Posted Date: 2022-06-21

Last Posted Date: 2023-11-22

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 106

Registration Number: NCT05423951

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Phase 4

Conditions: Hepatic Arterial Infusion Chemotherapy
Pain
Transarterial Chemoembolization
Hepatocellular Carcinoma

Interventions: Drug: Sufentanil
Drug: Esketamine

First Posted Date: 2022-06-13

Last Posted Date: 2023-02-24

Lead Sponsor: The Second Affiliated Hospital of Chongqing Medical University

Target Recruit Count: 70

Registration Number: NCT05416073

Locations: 🇨🇳
The Second Affiliated Hospital, Chongqing Medical University, Chongqing, Chongqing, China

Impact of Opioids on Heart Rate During Rapid Sequence Intubation

Not Applicable

Terminated

Conditions: Rapid Sequence Induction

Interventions: Drug: Remifentanil
Drug: Sufentanil
Drug: Placebo

First Posted Date: 2022-05-20

Last Posted Date: 2023-11-07

Lead Sponsor: Centre Hospitalier Sud Francilien

Target Recruit Count: 3

Registration Number: NCT05384665

Locations: 🇫🇷
Centre Hospitalier Sud Francilien, Corbeil-essonnes Cedex, France

Improving Pain Management and Decreasing LOS After Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA)

Phase 4

Conditions: Pain

Interventions: Drug: sufentanil

First Posted Date: 2022-04-01

Last Posted Date: 2022-04-01

Lead Sponsor: More Foundation

Target Recruit Count: 100

Registration Number: NCT05307341

Locations: 🇺🇸
The CORE Institute Specialty Hospital, Phoenix, Arizona, United States

Study on Opioid-free Anesthesia Protocol With S-ketamine and Propofol

Not Applicable

Conditions: S-ketamine
Opioid Use, Unspecified

Interventions: Drug: S-ketamine
Drug: Sufentanil

First Posted Date: 2022-02-16

Last Posted Date: 2022-07-20

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 980

Registration Number: NCT05242081

Locations: 🇨🇳
The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Opioid Free Anesthesia in Total Hip Arthroplasty

Phase 3

Completed

Conditions: Primary Total Hip Arthroplasty

Interventions: Drug: Sufentanil
Drug: Dexmedetomidine

First Posted Date: 2021-10-11

Last Posted Date: 2023-02-22

Lead Sponsor: CMC Ambroise Paré

Target Recruit Count: 80

Registration Number: NCT05072704

Locations: 🇫🇷
Clinique Médipôle Garonne, Toulouse, Haute-Garonne, France

Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Sufentanil

Phase 1

Completed

Conditions: Healthy

Interventions: Other: Placebo
Drug: Sufentanil

First Posted Date: 2021-07-13

Last Posted Date: 2024-07-11

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 46

Registration Number: NCT04959812

Locations: 🇺🇸
Institute for Exercise and Environmental Medicine, Dallas, Texas, United States
🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Study of CT001 in Healthy Volunteers

Phase 1

Completed

Conditions: Bioavailability

Interventions: Drug: CT001
Drug: sufentanil
Drug: Ketamine

First Posted Date: 2021-03-19

Last Posted Date: 2021-08-24

Lead Sponsor: Cessatech A/S

Target Recruit Count: 14

Registration Number: NCT04807335

Locations: 🇩🇰
Dantrials, Copenhagen, DK, Denmark

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy